Correlation Between Evaluator Conservative and Deutsche Health
Can any of the company-specific risk be diversified away by investing in both Evaluator Conservative and Deutsche Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evaluator Conservative and Deutsche Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evaluator Conservative Rms and Deutsche Health And, you can compare the effects of market volatilities on Evaluator Conservative and Deutsche Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evaluator Conservative with a short position of Deutsche Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evaluator Conservative and Deutsche Health.
Diversification Opportunities for Evaluator Conservative and Deutsche Health
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Evaluator and Deutsche is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Evaluator Conservative Rms and Deutsche Health And in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Deutsche Health And and Evaluator Conservative is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evaluator Conservative Rms are associated (or correlated) with Deutsche Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Deutsche Health And has no effect on the direction of Evaluator Conservative i.e., Evaluator Conservative and Deutsche Health go up and down completely randomly.
Pair Corralation between Evaluator Conservative and Deutsche Health
Assuming the 90 days horizon Evaluator Conservative Rms is expected to generate 0.31 times more return on investment than Deutsche Health. However, Evaluator Conservative Rms is 3.23 times less risky than Deutsche Health. It trades about 0.31 of its potential returns per unit of risk. Deutsche Health And is currently generating about 0.03 per unit of risk. If you would invest 979.00 in Evaluator Conservative Rms on September 4, 2024 and sell it today you would earn a total of 17.00 from holding Evaluator Conservative Rms or generate 1.74% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Evaluator Conservative Rms vs. Deutsche Health And
Performance |
Timeline |
Evaluator Conservative |
Deutsche Health And |
Evaluator Conservative and Deutsche Health Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Evaluator Conservative and Deutsche Health
The main advantage of trading using opposite Evaluator Conservative and Deutsche Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evaluator Conservative position performs unexpectedly, Deutsche Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deutsche Health will offset losses from the drop in Deutsche Health's long position.Evaluator Conservative vs. Evaluator Tactically Managed | Evaluator Conservative vs. Evaluator Moderate Rms | Evaluator Conservative vs. Evaluator Growth Rms | Evaluator Conservative vs. Evaluator Growth Rms |
Deutsche Health vs. Firsthand Technology Opportunities | Deutsche Health vs. Technology Ultrasector Profund | Deutsche Health vs. Dreyfus Technology Growth | Deutsche Health vs. Ivy Science And |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Transaction History View history of all your transactions and understand their impact on performance |